Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding
Others
Ratios

Applied Therapeutics (APLT) Interest & Investment Income (2023 - 2025)

Historic Interest & Investment Income for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to $144000.0.

  • Applied Therapeutics' Interest & Investment Income fell 8938.84% to $144000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 2846.39%. This contributed to the annual value of $3.5 million for FY2024, which is 15758.02% up from last year.
  • As of Q3 2025, Applied Therapeutics' Interest & Investment Income stood at $144000.0, which was down 8938.84% from $364000.0 recorded in Q2 2025.
  • Applied Therapeutics' Interest & Investment Income's 5-year high stood at $1.4 million during Q3 2024, with a 5-year trough of $144000.0 in Q3 2025.
  • Over the past 3 years, Applied Therapeutics' median Interest & Investment Income value was $408000.0 (recorded in 2023), while the average stood at $548636.4.
  • As far as peak fluctuations go, Applied Therapeutics' Interest & Investment Income soared by 24617.35% in 2024, and later plummeted by 8938.84% in 2025.
  • Applied Therapeutics' Interest & Investment Income (Quarter) stood at $352000.0 in 2023, then soared by 173.3% to $962000.0 in 2024, then tumbled by 85.03% to $144000.0 in 2025.
  • Its Interest & Investment Income stands at $144000.0 for Q3 2025, versus $364000.0 for Q2 2025 and $621000.0 for Q1 2025.